Boston Scientific (BSX) Share-based Compensation (2009 - 2026)

Boston Scientific (BSX) has 18 years of Share-based Compensation data on file, last reported at $83.0 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 12.16% year-over-year to $83.0 million; the trailing twelve-month figure through Mar 2026 stood at $308.0 million (up 11.19% YoY), and the FY2025 full-year result was $299.0 million, up 12.41% from the prior year.
• Share-based Compensation improved to $83.0 million in Q1 2026, from $71.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $83.0 million in Q1 2026 to a low of $52.0 million in Q1 2022.
• A 5-year average of $64.8 million and a median of $63.0 million in 2024 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation gained 1.72% in 2023 and increased 17.46% in 2025, its largest moves.
• Tracing BSX's Share-based Compensation over 5 years: stood at $55.0 million in 2022, then advanced by 7.27% to $59.0 million in 2023, then rose by 16.95% to $69.0 million in 2024, then grew by 2.9% to $71.0 million in 2025, then climbed by 16.9% to $83.0 million in 2026.
• Business Quant data shows BSX's Share-based Compensation at $83.0 million in Q1 2026, $71.0 million in Q4 2025, and $79.0 million in Q3 2025.